BIOMAT Database Logo BIOMAT Database Logo

Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region. 1989

M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, England.

Shortening of the overall duration of radiotherapy would reduce the possibility repopulation of tumor during treatment. Most clinical trials of such accelerated radiotherapy have incorporated a split course to improve normal tissue tolerance. Any interruption, however, even for the week-end, may allow repopulation to occur. A scheme of radiotherapy has been used during which treatment was given 3 times per day on each of 12 consecutive days without interruption for the week-end. In a pilot study a significant improvement in survival and local tumor control has been achieved in 48 patients with head and neck tumors when comparison was made with a previously treated group. A randomized controlled clinical trial is planned.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Hyperfractionated accelerated radiotherapy in locally advanced head and neck cancers.
October 2007, Onkologie,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Continuous hyperfractionated accelerated radiotherapy in advanced head and neck malignancies.
March 1998, Indian journal of cancer,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.
January 2005, Head & neck,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Accelerated and hyperfractionated radiotherapy in advanced head and neck tumors: rebuttal.
January 1988, International journal of radiation oncology, biology, physics,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer.
October 2002, American journal of clinical oncology,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma.
October 2008, Investigational new drugs,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
April 2000, International journal of cancer,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Accelerated hyperfractionated radiotherapy for locally advanced cervix cancer.
June 1999, International journal of radiation oncology, biology, physics,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
November 1998, International journal of radiation oncology, biology, physics,
M I Saunders, and S Dische, and A Hong, and E J Grosch, and D C Fermont, and R F Ashford, and E J Maher
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
November 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Copied contents to your clipboard!